Susquehanna International Group
HCAT icon

Susquehanna International Group’s Health Catalyst HCAT Stock Holding History

Susquehanna International Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103K Buy
81,154
+53,830
+197% +$101K ﹤0.01% 12321
2025
Q4 		$65.3K Sell
27,324
-17,004
-38% -$46.5K ﹤0.01% 11656
2025
Q3 		$126K Sell
44,328
-110,855
-71% -$379K ﹤0.01% 11411
2025
Q2 		$585K Buy
155,183
+49,559
+47% +$195K ﹤0.01% 8813
2025
Q1 		$478K Buy
105,624
+2,174
+2% +$11.5K ﹤0.01% 8991
2024
Q4 		$731K Sell
103,450
-30,923
-23% -$246K ﹤0.01% 7719
2024
Q3 		$1.09M Buy
134,373
+102,125
+317% +$738K ﹤0.01% 6583
2024
Q2 		$206K Sell
32,248
-17,392
-35% -$112K ﹤0.01% 10295
2024
Q1 		$374K Buy
49,640
+7,963
+19% +$72.7K ﹤0.01% 9186
2023
Q4 		$386K Buy
41,677
+189
+0.5% +$1.54K ﹤0.01% 9271
2023
Q3 		$420K Sell
41,488
-35,192
-46% -$420K ﹤0.01% 8638
2023
Q2 		$959K Buy
76,680
+21,529
+39% +$256K ﹤0.01% 6774
2023
Q1 		$644K Buy
55,151
+30,325
+122% +$387K ﹤0.01% 7954
2022
Q4 		$264K Sell
24,826
-50,414
-67% -$487K ﹤0.01% 9418
2022
Q3 		$730K Buy
+75,240
New +$996K ﹤0.01% 7455
2022
Q1 		– Sell
-18,397
Closed -$522K – 13396
2021
Q4 		$729K Buy
18,397
+10,460
+132% +$477K ﹤0.01% 8138
2021
Q3 		$397K Buy
+7,937
New +$433K ﹤0.01% 9956
2021
Q1 		– Sell
-6,958
Closed -$337K – 12463
2020
Q4 		$303K Sell
6,958
-2,293
-25% -$84.6K ﹤0.01% 9227
2020
Q3 		$339K Sell
9,251
-17,725
-66% -$602K ﹤0.01% 8465
2020
Q2 		$787K Buy
26,976
+14,385
+114% +$398K ﹤0.01% 6427
2020
Q1 		$329K Buy
+12,591
New +$385K ﹤0.01% 7801

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group's HCAT Position: Q1 2026 in Review

Susquehanna International Group increased its Health Catalyst (HCAT) stake by 197% in Q1 2026, buying an estimated $101K and bringing the position to 81,154 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #12321.

Susquehanna International Group first reported a position in HCAT in Q1 2020 and has held it in 21 quarters since. The position peaked at $1.09M in Q3 2024. 131 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Susquehanna International Group held 81,154 shares of Health Catalyst worth $103K as of Q1 2026.
  • Susquehanna International Group bought 53,830 Health Catalyst shares in Q1 2026, an estimated $101K.
  • Health Catalyst made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12321 holding.
  • Susquehanna International Group first reported a position in Health Catalyst in Q1 2020 and has held it in 21 quarters since.
  • Susquehanna International Group's Health Catalyst position peaked at $1.09M in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.